Outcomes in COVID-19 patients with acute cholangitis: a single-center retrospective analysis
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S466
DOI: 10.1055/s-0044-1783878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von D. Vuletici und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
The aim of this study was to appraise the impact of COVID-19 infection on patients with acute cholangitis (AC), to compare the outcomes, complications and hospital stay in a tertiary Gastroenterology department.
Methods
This study is designed as a retrospective observational cohort single center study performed in a tertiary department of gastroenterology to investigate the confluence of COVID-19 and AC. Data were collected from patients with AC and COVID-19 between April 2020 and February 2022. Clinical and demographic data were collected systematically, retrospectively, encompassing COVID-19-specific information, cholangitis presentation, medical records, laboratory results, and medical interventions. The AC diagnosis was determined following the TG18 criteria, with all patients undergoing the collection of a bile culture sample. This study investigates the clinical characteristics of patients with and without COVID-19 undergoing endoscopic retrograde cholangiopancreatography (ERCP).
Results
A total of 241 patients were included, with 30 in the COVID group and 211 in the non-COVID group. The analysis focused on various demographic and clinical parameters, aiming to identify significant differences between the two groups. The mean age of COVID patients was significantly higher than that of non-COVID patients (74.3 vs. 67.3 years, p=0.009). Gender distribution did not show a significant difference between the two groups (p=0.539). Abdominal pain was more prevalent in the COVID group (90.0% vs. 70.6%, p=0.025). Notably, the presence of sterile bile cultures was significantly associated with the COVID group (p=0.040). Several diagnostic categories were explored, revealing significant differences in the causes of obstruction between the two groups (p=0.022). COVID patients had a higher incidence of complications such as cholangiocarcinoma and neoplastic involvement. The severity of cases, as assessed by the Tokyo severity classification, showed no significant difference between the groups (p=0.103). Clinical markers, including white blood cell count, total bilirubin, platelet count, international normalized ratio, and C-reactive protein, did not differ significantly between the groups. However, the duration of hospitalization was significantly longer for COVID patients (p
Zitieren
APA
Vuletici, D., Miutescu, B., Ratiu, I., Moga, T., Calin, B., Bende, F., & Popescu, A. (2024). Outcomes in COVID-19 patients with acute cholangitis: a single-center retrospective analysis. Endoscopy, 56(S 02 S 02), S466. https://doi.org/10.1055/s-0044-1783878
Vancouver
Vuletici D, Miutescu B, Ratiu I, Moga T, Calin B, Bende F, et al. Outcomes in COVID-19 patients with acute cholangitis: a single-center retrospective analysis. Endoscopy. 2024;56(S 02 S 02):S466. doi:10.1055/s-0044-1783878
BibTeX
@article{Vuletici2024,
author = {Vuletici, D. and Miutescu, B. and Ratiu, I. and Moga, T. and Calin, B. and Bende, F. and Popescu, A.},
title = {Outcomes in COVID-19 patients with acute cholangitis: a single-center retrospective analysis},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S466},
doi = {10.1055/s-0044-1783878}
}
EUVIMED